PharmNovo
Carl-Magnus Andersson has extensive experience in drug discovery and development and has held senior positions within a number of pharma and biotech companies, including AstraDraco, Acadia pharmaceuticals and KaroBio, were responsible for the chemical and pharmaceutical sciences and also intellectual property strategies. Associate professor of pharmaceutical chemistry and co-authored more than 100 scientific papers and patent applications.
This person is not in any offices
PharmNovo
PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.